Literature DB >> 7981311

Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system.

C Raffel1, K Culver, D Kohn, M Nelson, S Siegel, F Gillis, C J Link, J G Villablanca, W F Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7981311     DOI： 10.1089/hum.1994.5.7-863

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  10 in total

Review 1.  The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors.

Authors:  S S Andreansky; B He; G Y Gillespie; L Soroceanu; J Markert; J Chou; B Roizman; R J Whitley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

2.  Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.

Authors:  M E Black; T G Newcomb; H M Wilson; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 3.  Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.

Authors:  T M Clay; M C Custer; P J Spiess; M I Nishimura
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 4.  The evolution and application of techniques in molecular biology to human brain tumors: a 25 year perspective.

Authors:  James T Rutka; Paul Kongkham; Paul Northcott; Carlos Carlotti; Mustafa Guduk; Hirokatsu Osawa; Orlando Moreno; Ho Jun Seol; Andres Restrepo; Adrienne Weeks; Shoichi Nagai; Christian Smith
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

Review 5.  Adenovirus gene therapy for pediatric cancers: shall we gather at the liver?

Authors:  James I Geller; Timothy P Cripe
Journal:  Pediatr Blood Cancer       Date:  2009-08       Impact factor: 3.167

Review 6.  Adenoviral virotherapy for malignant brain tumors.

Authors:  Suvobroto Nandi; Maciej S Lesniak
Journal:  Expert Opin Biol Ther       Date:  2009-06       Impact factor: 4.388

7.  Gene therapy trials for the treatment of high-grade gliomas.

Authors:  Adam M Sonabend; Ilya V Ulasov; Maciej S Lesniak
Journal:  Gene Ther Mol Biol       Date:  2007

8.  Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK.

Authors:  B Degrève; M Johansson; E De Clercq; A Karlsson; J Balzarini
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?

Authors:  E Bouffet; F Doz; M C Demaille; P Tron; H Roche; D Plantaz; A Thyss; J L Stephan; O Lejars; E Sariban; M Buclon; J M Zücker; M Brunat-Mentigny; J L Bernard; J C Gentet
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

Review 10.  Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness.

Authors:  Valentina Bova; Alessia Filippone; Giovanna Casili; Marika Lanza; Michela Campolo; Anna Paola Capra; Alberto Repici; Lelio Crupi; Gianmarco Motta; Cristina Colarossi; Giulia Chisari; Salvatore Cuzzocrea; Emanuela Esposito; Irene Paterniti
Journal:  Cancers (Basel)       Date:  2022-08-20       Impact factor: 6.575
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.